The Director shall release a statement of drug control policy priorities in the calendar year of a Presidential inauguration following the inauguration, but not later than April 1.
Not later than the first Monday in February following the year in which the term of the President commences, and every 2 years thereafter, the President shall submit to Congress a National Drug Control Strategy.
The Director shall promulgate the National Drug Control Strategy, which shall set forth a comprehensive plan to reduce illicit drug use and the consequences of such illicit drug use in the United States by limiting the availability of and reducing the demand for illegal drugs and promoting prevention, early intervention, treatment, and recovery support for individuals with substance use disorders.
The Director shall seek the support and commitment of State, local, and Tribal officials in the formulation and implementation of the National Drug Control Strategy.
The Director shall ensure the National Drug Control Strategy is based on the best available evidence regarding the policies that are most effective in reducing the demand for and supply of illegal drugs.
In developing and effectively implementing the National Drug Control Strategy, the Director-
The National Drug Control Strategy submitted under subsection (a)(2) shall include the following:
In developing the plan required under paragraph (1)(M), the Director shall consult with the following:
The Director shall include in the National Drug Control Strategy the additional strategies described under this paragraph and shall comply with the following:
The Southwest Border Counternarcotics Strategy shall-
The Southwest Border Counternarcotics Strategy shall include-
The Northern Border Counternarcotics Strategy shall-
The Northern Border Counternarcotics Strategy shall include-
Any contents of the National Drug Control Strategy that involve information properly classified under criteria established by an Executive order shall be presented to Congress separately from the rest of the National Drug Control Strategy.
In selecting data and information for inclusion in the Strategy, the Director shall ensure-
The President may submit to Congress a revised National Drug Control Strategy that meets the requirements of this section-
If the Director does not submit a National Drug Control Strategy to Congress in accordance with subsection (a)(2), not later than five days after the first Monday in February following the year in which the term of the President commences, the Director shall send a notification to the appropriate congressional committees-
The Director shall collect and disseminate, as appropriate, such information as the Director determines is appropriate, but not less than the information described in this subsection. The data shall be publicly available in a machine-readable format on the online portal of the Office, and to the extent practicable on the Drug Control Data Dashboard.
The Director shall publish to the online portal of the Office in a machine-readable, sortable, and searchable format, or to the extent practicable, establish and maintain a data dashboard on the online portal of the Office to be known as the "Drug Control Data Dashboard". To the extent practicable, when establishing the Drug Control Dashboard, the Director shall ensure the user interface of the dashboard is constructed with modern design standards. To the extent practicable, the data made available on the dashboard shall be publicly available in a machine-readable format and searchable by year, agency, drug, and location.
The data included in the Drug Control Data Dashboard shall be updated quarterly to the extent practicable, but not less frequently than annually and shall include, at a minimum, the following:
Not later than the first Monday in February of each year, the Director shall submit to the President, Congress, and the appropriate congressional committees, a report assessing the progress of each National Drug Control Program agency toward achieving each goal, objective, and target contained in the National Drug Control Strategy applicable to the prior fiscal year.
Not later than November 1 of each year, the head of each National Drug Control Program agency shall submit, in accordance with guidance issued by the Director, to the Director an evaluation of progress by the agency with respect to the National Drug Control Strategy goals using the performance measures for the agency developed under this chapter, including progress with respect to-
The Director shall include in the annual assessment required under paragraph (1)-
Not later than February 1 of each year, the Director shall submit to Congress as part of the National Drug Control Strategy, a description of a national drug control performance measurement system, that-
A description of any modifications made during the preceding year to the national drug performance measurement system described in subsection (c)4 shall be included in each report submitted under subsection (b).5
1So in original. The comma probably should not appear.
2So in original. Probably should be followed by "and".
3So in original.
4Probably should be "(h)".
5Probably should be "(d)".
21 U.S.C. § 1705
EDITORIAL NOTES
REFERENCES IN TEXTThe Federal Food, Drug, and Cosmetic Act, referred to in subsec. (f)(3)(A)(i)(IV), is act June 25, 1938, ch. 675, 52 Stat. 1040, which is classified generally to chapter 9 (§301 et seq.) of this title. For complete classification of this Act to the Code, see section 301 of this title and Tables.This chapter, referred to in subsec. (g)(2), (3)(B), was in the original "this title", meaning title VII of div. C of Pub. L. 105-277, 112 Stat. 2681-670, which is classified principally to this chapter. For complete classification of title VII to the Code, see Short Title note set out under section 1701 of this title and Tables.
AMENDMENTS2022-Subsec. (h)(7). Pub. L. 117-263 added par. (7). 2019- Pub. L. 116-74, §2(c)(1)(B), amended directory language of Pub. L. 115-271, §8221(a). See 2018 Amendment note below. Pub. L. 116-74, §2(a)(2), substituted "National Drug Control Program agencies" for "National Drug Control Program Agencies" wherever appearing. Pub. L. 116-74, §2(a)(1), substituted "National Drug Control Program agency" for "National Drug Control Program Agency" wherever appearing.Subsec. (c)(1)(N)(ii). Pub. L. 116-74, §2(d)(1)(A), substituted "Program agencies" for "Programs". Subsec. (c)(1)(N)(iii). Pub. L. 116-74, §2(d)(1)(B), substituted "Program agencies" for "Agencies". Subsec. (c)(2). Pub. L. 116-74, §2(d)(2), substituted "paragraph (1)(M)" for "paragraph (1)" in introductory provisions. Subsec. (f)(2). Pub. L. 116-74, §2(d)(3)(A), substituted "Office" for "office".Subsec. (f)(3)(A)(ii)(III). Pub. L. 116-74, §2(d)(3)(B)(i), substituted "substance; and" for "substance;". Subsec. (f)(3)(A)(ii)(IV). Pub. L. 116-74, §2(d)(3)(B)(ii), substituted "governments." for "governments;".Subsec. (g)(3)(B). Pub. L. 116-74, §2(d)(4), made technical amendment to reference in original act which appears in text as reference to this chapter. 2018- Pub. L. 115-271, §8221(a), as amended by Pub. L. 116-74, §2(c)(1)(B)(ii), added subsecs. (a) to (g), redesignated former subsecs. (c) and (d) as (h) and (i), respectively, and struck out former subsecs. (a) and (b) which related to submission of the National Drug Control Strategy and submission of a revised strategy. Pub. L. 115-271, §8202(b)(2), repealed Pub. L. 105-277, §715. See 1998 Amendment note below. Pub. L. 115-271, §8202(a), revived and restored this section as in effect on Sept. 29, 2003, and as amended by Pub. L. 109-469 and Pub. L. 112-166. See Reauthorization of the Office of National Drug Control Policy note set out under section 1701 of this title. 2006- Pub. L. 109-469, §602, amended Pub. L. 105-277, §715, which provided for the repeal of this section. See 1998 Amendment note below. Pub. L. 109-469, §201, amended section generally. Prior to amendment, section related to development, submission, implementation, and assessment of National Drug Control Strategy.Subsecs. (c), (d). Pub. L. 109-469, §202, added subsecs. (c) and (d). 1998- Pub. L. 105-277, §715, as amended by Pub. L. 109-469, §602, which provided for the repeal of this section effective Sept. 30, 2010, was repealed by Pub. L. 115-271, §8202(b)(2). See former section 1712 of this title.
STATUTORY NOTES AND RELATED SUBSIDIARIES
EFFECTIVE DATE OF 2019 AMENDMENT Amendment by section 2(c)(1)(B) of Pub. L. 116-74 effective as if included in the enactment of subtitle K of title VIII of Pub. L. 115-271 see section 2(c)(2) of Pub. L. 116-74 set out as a note under section 1522 of this title.
REQUIREMENT FOR SOUTHWEST BORDER COUNTERNARCOTICS STRATEGY Pub. L. 109-469, title XI, §11101110,, 120 Stat. 3543, which directed the Director of National Drug Control Policy to submit to Congress every two years a Southwest Border Counternarcotics Strategy, was repealed by Pub. L. 115-271, title VIII, §8221(b)(2), Oct. 24, 2018, 132 Stat. 4142. See subsection (c)(3)(B) of this section.
REQUIREMENT FOR NORTHERN BORDER COUNTERNARCOTICS STRATEGY Pub. L. 109-469, title XI, §1110A, as added by Pub. L. 111-356, §2, Jan. 4, 2011, 124 Stat. 3976, which directed the Director of National Drug Control Policy to develop, in consultation with the head of each relevant National Drug Control Program Agency, and to submit to Congress every two years, a Northern Border Counternarcotics Strategy, was repealed by Pub. L. 115-271, title VIII, §8221(b)(2), Oct. 24, 2018, 132 Stat. 4142. See subsection (c)(3)(C) of this section.
- Director
- The term "Director" means the Director of National Drug Control Policy.
- National Drug Control Program agency
- The term "National Drug Control Program agency" means any agency (or bureau, office, independent agency, board, division, commission, subdivision, unit, or other component thereof) that is responsible for implementing any aspect of the National Drug Control Strategy, including any agency that receives Federal funds to implement any aspect of the National Drug Control Strategy, but does not include any agency that receives funds for drug control activity solely under the National Intelligence Program or the Joint Military Intelligence Program.
- National Drug Control Program
- The term "National Drug Control Program" means programs, policies, and activities undertaken by National Drug Control Program agencies pursuant to the responsibilities of such agencies under the National Drug Control Strategy, including any activities involving supply reduction, demand reduction, or State, local, and tribal1 affairs.
- Office
- The term "Office" means the Office of National Drug Control Policy established under section 1702(a) of this title.
- demand reduction
- The term "demand reduction" means any activity conducted by a National Drug Control Program agency, other than an enforcement activity, that is intended to reduce or prevent the use of drugs or support, expand, or provide treatment and recovery efforts, including-(A) education about the dangers of illicit drug use;(B) services, programs, or strategies to prevent substance use disorder, including evidence-based education campaigns, community-based prevention programs, collection and disposal of unused prescription drugs, and services to at-risk populations to prevent or delay initial use of an illicit drug;(C) substance use disorder treatment;(D) support for long-term recovery from substance use disorders;(E) drug-free workplace programs;(F) drug testing, including the testing of employees;(G) interventions for illicit drug use and dependence;(H) expanding availability of access to health care services for the treatment of substance use disorders;(I) international drug control coordination and cooperation with respect to activities described in this paragraph;(J) pre- and post-arrest criminal justice interventions such as diversion programs, drug courts, and the provision of evidence-based treatment to individuals with substance use disorders who are arrested or under some form of criminal justice supervision, including medication assisted treatment;(K) other coordinated and joint initiatives among Federal, State, local, and Tribal agencies to promote comprehensive drug control strategies designed to reduce the demand for, and the availability of, illegal drugs;(L) international illicit drug use education, prevention, treatment, recovery, research, rehabilitation activities, and interventions for illicit drug use and dependence; and(M) research related to illicit drug use and any of the activities described in this paragraph.
- drug control
- The term "drug control" means any activity conducted by a National Drug Control Program agency involving supply reduction or demand reduction.
- substance use disorder treatment
- The term "substance use disorder treatment" means an evidence-based, professionally directed, deliberate, and planned regimen including evaluation, observation, medical monitoring, and rehabilitative services and interventions such as pharmacotherapy, behavioral therapy, and individual and group counseling, on an inpatient or outpatient basis, to help patients with substance use disorder reach recovery.
- supply reduction
- The term "supply reduction" means any activity or program conducted by a National Drug Control Program agency that is intended to reduce the availability or use of illegal drugs in the United States or abroad, including-(A) law enforcement outside the United States;(B) domestic law enforcement;(C) source country programs, including economic development programs primarily intended to reduce the production or trafficking of illicit drugs;(D) activities to control international trafficking in, and availability of, illegal drugs, including-(i) accurate assessment and monitoring of international drug production and interdiction programs and policies; and(ii) coordination and promotion of compliance with international treaties relating to the production, transportation, or interdiction of illegal drugs;(E) activities to conduct and promote international law enforcement programs and policies to reduce the supply of drugs;(F) activities to facilitate and enhance the sharing of domestic and foreign intelligence information among National Drug Control Program agencies, relating to the production and trafficking of drugs in the United States and in foreign countries;(G) activities to prevent the diversion of drugs for their illicit use; and(H) research related to any of the activities described in this paragraph.1So in original. Probably should be "Tribal".